今年以来，随着二级市场行情反转，越来越多的公司在股价拉升的时候，选择了逢高减持。不过在一众 减持企业当中，也有在行情利好下，股价持续低迷却选择减持的。 2025年7月8日，超图软件(300036.SZ)的控股股东、实控人和一众高管因自身资金需求，抛出了减持 单。 股价低迷，实控人及部分高管宣布减持 公开资料显示，超图软件早在2009年就已经上市，是一家焦地理信息系统相关软件技术研发与应用服 务，下设基础软件、应用软件、云服务三大GIS业务块板。 据了解，超图软件发行价为19.80元/股，公司股价曾一度涨至69元/股。不过近几年以来，公司股价一直 处于震荡下降的趋势。 即使在今年整体大盘回暖的时候，超图软件的股价也持续表现低迷。数据显示，截至到7月9日收盘，超 图软件报价14.76元/股，年内跌幅达到13.07%，就目前来看，公司股价已经连续两年持续下跌趋势当 中。 昨日晚间，超图软件宣布了公司控股股东和一众高管的减持预披露公告。 公告指出，公司控股股东、实际控制人及董事钟耳顺计划以集中竞价或大宗交易方式减持不超过965.61 万股，占公司总股本2%。公司副总经理白杨建、谭飞艳、荆钺坤拟分别通过集中竞价方式减持 ...

Core Viewpoint - Heng Rui Medicine's stock experienced a significant surge, with a maximum increase of over 18% in Hong Kong and over 8% in A-shares, following a buy rating from Citigroup, which highlighted the market's underestimation of the company's business development (BD) expectations and the rapid launch of several innovative drugs [2][5]. Group 1: Stock Performance and Analyst Ratings - On July 9, Heng Rui Medicine's Hong Kong stock price reached 68 HKD, with a rise of 12.96%, while the A-share price was 57.1 CNY, up 6.93%, resulting in a market capitalization of 380.2 billion CNY [2]. - Citigroup assigned a buy rating for Heng Rui Medicine's H-shares with a target price of 134 HKD and an A-share target price of 123 CNY, citing significant catalysts from upcoming performance and BD developments [2][5]. Group 2: Clinical Trials and Drug Approvals - Heng Rui Medicine announced the approval of clinical trials for two new drugs: SHR-2173 injection, aimed at treating primary membranous nephropathy, and HRS-9821 inhalation powder, intended for chronic obstructive pulmonary disease (COPD) maintenance therapy [4][6]. - SHR-2173 is a biologic targeting abnormally activated immune cells, while HRS-9821 is a small molecule PDE3/PDE4 inhibitor, with the latter expected to compete with Ensifentrine, which is projected to generate approximately 42 million USD in sales in 2024 [4][6]. Group 3: Research and Development Progress - Heng Rui Medicine has 23 first-class innovative drugs and 4 second-class new drugs approved in China, with 8 first-class innovative drugs launched in 2024 alone [8]. - The company has invested 46 billion CNY in R&D, with R&D expenditure accounting for 29.4% of sales revenue in 2024, positioning it among the top in the pharmaceutical industry [8]. - The company is expected to have over 40 innovative products approved for market launch in the next three years, covering various therapeutic areas including oncology, metabolism, cardiovascular, immune, and respiratory diseases [9].

【导读】恒瑞医药港股午后突然大幅拉升，最大涨幅超18% 中国基金报记者 卢鸰 千亿医药巨头突然暴涨。 7月9日，恒瑞医药港股午后突然大幅拉升，最大涨幅超18%，A股同时最高暴涨超8%。 花旗7月9日发布报告称，首次给予恒瑞医药H股买入评级，目标价为134港元，A股目标价为 123元。花旗称，市场没有充分反映恒瑞医药的BD（商务拓展）预期，以及多款创新药的快 速放量，后续的业绩和BD进展都会是重要催化剂。 7月8日晚，恒瑞医药发布公告称，近日，公司子公司广东恒瑞医药有限公司收到国家药监局 核准签发关于SHR-2173注射液和HRS-9821吸入粉雾剂的《药物临床试验批准通知书》， 将于近期开展临床试验。 据公告披露，SHR-2173注射液是公司自主研发的治疗用生物制品，能够通过靶向异常激活 的免疫细胞，发挥抗炎和抑制免疫的生物学效应，有望降低自身抗体水平，改善原发性膜性 肾病患者的疾病活动状态，为患者带来新的治疗选择。目前国内外尚无同类药物上市或在临 床研发阶段。 HRS-9821是小分子PDE3/PDE4抑制剂，可有效抑制呼吸道炎症、扩张支气管，临床拟用于 慢性阻塞性肺疾病（COPD）的维持治疗。目前全球同类 ...

Core Viewpoint - The State Administration for Market Regulation and the Ministry of Industry and Information Technology have issued an action plan for metrology support in the development of new productive forces in industries from 2025 to 2030, focusing on key measurement technologies in aerospace and aviation sectors [1] Group 1: Key Measurement Technologies - The plan emphasizes research on critical common measurement technologies for spacecraft operation in orbit, satellite remote sensing and communication, space exploration, intelligent manufacturing of commercial aircraft, and low-altitude aircraft [1] - It aims to develop a prototype of a quantum natural standard for space use and conduct typical experimental validations [1] - The initiative addresses challenges such as long-term vacuum leakage in space stations and the measurement of material outgassing rates [1] Group 2: Industry Applications - The research will tackle key parameter measurement and calibration technologies for intelligent perception, positioning navigation, and energy power in low-altitude aircraft [1] - It will also focus on intelligent detection and online calibration technologies for comprehensive parameters in commercial aircraft, commercial remote sensing, and satellite internet fields [1] - The goal is to create typical application demonstrations that promote collaborative innovation in aerospace technology [1]

Core Viewpoint - The State Administration for Market Regulation and the Ministry of Industry and Information Technology have issued an action plan aimed at advancing key common measurement technology research for high-end measuring instruments from 2025 to 2030, focusing on domestic substitution and technological innovation in the field of instrumentation [1] Group 1: Key Technologies and Research Focus - The action plan emphasizes the research of key common measurement technologies for high-end measuring instruments, including millimeter-wave, terahertz electronic instruments, online intelligent measurement mass spectrometers, high-precision atomic gravimeters, and high-precision ultra-large force measurement devices [1] - The goal is to address measurement testing needs related to the basic processes, core algorithms, key components, and core technical indicators of mid-to-high-end products [1] Group 2: Industry Development Goals - The initiative aims to enhance the engineering and industrialization capabilities of typical mid-to-high-end instrument products [1] - It also seeks to strengthen the measurement testing and evaluation capabilities of instruments and meters, supporting technological innovation in typical instrument products through improved measurement technology levels [1] - The plan promotes the domestic substitution of instrumentation, aiming to reduce reliance on foreign technology and products [1]

谁说站在光里的才算英雄，累计亏损超过千亿的蔚来，还是想做那个"孤勇者"。 李斌正面回应蔚来千亿亏损 蔚来的李斌，又用一句话把自己送上了热搜。 就在前两日，蔚来创始人李斌在微博开启了直播。 彼时的他，正在陪同吴晓波及百余位企业家参访合肥蔚来工厂。 对着镜头，李斌表示，蔚来一直以来的底色是技术创新，累计研发投入达到600亿元。 图源：ZAKER 他还直言： "蔚来是全球唯一的在三地上市的汽车公司，蔚来财报里把研发投入计成当期费用，钱都亏在明处，资产负债表非常干净。" 一石激起千层浪，对于李斌的这番言论，网友的评论并不宽容。 诸如"第二个贾跃亭""必须盯紧他，别跑了"成为热评关键词，质疑声纷至沓来。 图源：今日头条 网友的担忧并非空穴来风。 原因很简单，李斌此番表态的背后，是一个绕不开的事实：蔚来自成立以来，已累计亏损超过1000亿元。 尤其在2025年一季度，据财报显示，蔚来的营收虽然超120亿元，同比增长超21%，净亏损却依旧达到67.5亿元，同比扩大30.2%。 此外，蔚来的资产负债率高达92.55%，远超行业70%的警戒线，现金储备也锐减至260亿，甚至即期可动用资金已不足81亿。 结合其过往财报数据，蔚来 ...

| 导读： 科技部发布2025年度第三批国际科技创新合作项目指南，设5个方向，支持与4国合作，拟资助约21个项目，总经费1.02亿元，要求中外合著论文半数发 表于我国期刊。 | | --- | | 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 根据科技部国际合作司7月2日发布，科技部"政府间国际科技创新合作"重点专项2 0 2 5年度第三批项目申报指南发布。2 0 2 5年度第三批项目设 | | 立5个指南方向，支持与4个国家开展科技合作，拟支持项目数约2 1个，国拨经费总概算 1 . 0 2亿元人民币 。项目不下设课题。要求项目形成的 | | 中外合著论文中， 发表在我国科技期刊上的比例不低于5 0% 。 | | 根据国家科学技术奖励工作办公室5月2 8日的说明，国内期刊的认定标准有所调整： 虽然没有CN号，但由我国机构和个人实际控股的期刊 ， 也可被认定为国内期刊。 | 具体内容如下: 科技部国际合作司关于发布国家重点研发计划"政府间国际科技创新合作"重点专项2 0 2 5年度第三批项目申报指南的通知 各省、自治区、直辖市及计划单列市 ...

中国科学院大连化物所 【动态】大连化物所研制出深海原位气相色谱-质谱联用仪和色氨酸荧光传感器 原创 阅读全文 分享一篇文章。 ...

Group 1: Apple Leadership Transition - Apple's hardware engineering chief, John Ternus, is being considered as the most likely successor to CEO Tim Cook, following the announcement of COO Jeff Williams' retirement at the end of the year [1] - The Apple board is looking for a long-term executive, similar to Cook and Steve Jobs, who can remain in the role for at least a decade [1] Group 2: macOS 26 Updates - The macOS 26 Beta 3 has optimized the Safari browser and Terminal application tabs by removing a black bar and improving contrast for better visibility of active tabs [2] - The introduction of the ASIF disk image format in macOS 26 significantly enhances disk image processing capabilities, achieving read speeds of up to 5.8 GB/s and write speeds of 6.6 GB/s on M3 Pro MacBook Pro [6][7] Group 3: Apple Pencil Innovation - Apple has been granted a patent for a new design of the Apple Pencil that allows writing on any surface, moving away from reliance on the iPad's screen [3][4] - The technology involves optical sensors within the Apple Pencil, enabling it to detect movements and distances from surfaces, thus allowing for a versatile writing experience [6] Group 4: New Chip Developments - Apple is reportedly developing a new Wi-Fi and Bluetooth chip named Proxima, which is expected to be used in future iPhone, iPad, Mac, Apple TV, and HomePod mini models [8][9] - This new chip aims to replace current chips supplied by Broadcom and is anticipated to support Wi-Fi 6E or Wi-Fi 7, enhancing connectivity for devices like Apple TV and HomePod mini [9] Group 5: Industry Events - GAC Fiat Chrysler has officially declared bankruptcy due to an inability to repay debts and insufficient assets, marking a significant event in the automotive industry [10] - The company had been in bankruptcy proceedings since late 2022, with its Guangzhou factory being repurposed for electric vehicle production [10]

Core Viewpoint - The successful listing of YingShi Innovation (688775.SH) on the Sci-Tech Innovation Board highlights its rapid growth as a leading smart imaging brand, driven by innovative panoramic imaging technology and a keen understanding of market trends [1][2]. Group 1: Product Development and Innovation - Continuous technological innovation is essential for addressing unmet user needs, with profits reinvested into R&D to create a virtuous cycle of innovation [3][6]. - The company focuses on original product development, having chosen this path over imitation, which has been crucial to its growth and market leadership [4][5]. - Identifying high-margin markets with existing demand but unresolved pain points is a key strategy for product development [3][8]. Group 2: Market Strategy and Consumer Insights - The company emphasizes understanding customer needs and addressing issues that competitors have overlooked, which is fundamental to its innovation strategy [5][6]. - The successful launch of the flagship product X5, a 360-degree camera, is attributed to its ability to solve previous product pain points and meet consumer expectations [10][11]. - The company aims to expand its target customer base and application scenarios as it resolves existing product issues, thereby increasing market penetration [12][9]. Group 3: AI and Future Opportunities - The integration of AI technology is seen as a significant opportunity for enhancing product capabilities, such as automatic shooting and editing, although it presents substantial engineering challenges [14][15]. - The company’s mission remains focused on helping people better record and share their lives, with a long-term vision of becoming a world-class smart imaging brand [13][12]. Group 4: Investment and Growth Strategy - The company advises startups to focus on high-end product development to ensure profitability and sustainable growth, rather than engaging in price wars [16][17]. - Emphasizing the importance of operational efficiency and patent registration is crucial for companies looking to expand globally [18][17]. - The partnership with Qiming Venture Partners has been instrumental in the company's growth, providing not only financial support but also valuable resources and insights [20][22].